tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe FlyJohnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
J&J confirms FDA approves quadruplet regimen for multiple myeloma
Premium
The Fly
J&J confirms FDA approves quadruplet regimen for multiple myeloma
10d ago
FDA approves Darzalex Faspro combo for newly diagnosed multiple myeloma
Premium
The Fly
FDA approves Darzalex Faspro combo for newly diagnosed multiple myeloma
10d ago
Johnson & Johnson price target raised to $200 from $197 at Morgan Stanley
PremiumThe FlyJohnson & Johnson price target raised to $200 from $197 at Morgan Stanley
15d ago
Johnson & Johnson price target raised to $220 from $205 at Stifel
Premium
The Fly
Johnson & Johnson price target raised to $220 from $205 at Stifel
15d ago
Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs
Premium
The Fly
Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs
15d ago
Johnson & Johnson Projects Strong Growth Beyond STELARA
PremiumCompany AnnouncementsJohnson & Johnson Projects Strong Growth Beyond STELARA
16d ago
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
Premium
The Fly
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
16d ago
Johnson & Johnson says ‘very confident’ in 2026 outlook
Premium
The Fly
Johnson & Johnson says ‘very confident’ in 2026 outlook
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100